# A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)

> **NCT02057913** · PHASE2 · COMPLETED · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 22 (actual)

## Conditions studied

- Locally-advanced or Metastatic Penile Neoplasms

## Interventions

- **DRUG:** Vinflunine

## Key facts

- **NCT ID:** NCT02057913
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-17
- **Primary completion:** 2018-11-06
- **Final completion:** 2018-11-06
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057913, "A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02057913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*